Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-0.14%
$163.47
0% positive prob.
5-Day Prediction
-2.58%
$159.48
0% positive prob.
20-Day Prediction
-3.62%
$157.77
0% positive prob.
SEC 8-K filings with transcript text
Feb 27, 2026 · 100% conf.
1D
-0.14%
$163.47
5D
-2.58%
$159.48
20D
-3.62%
$157.77
nhc20260225_8k.htm
false 0001047335
0001047335
2026-02-27 2026-02-27
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2026 (February 26, 2026)
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
National HealthCare Corporation (“NHC”) issued a press release on February 26, 2026, announcing its December 31, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
(d)
Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on February 26, 2026 by National HealthCare Corporation announcing December 31, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 27, 2026
By:/s/
Brian F. Kidd
Name: Brian F. Kidd
Title: Senior VP/Chief Financial Officer
Nov 7, 2025
nhc20251106c_8k.htm
false 0001047335
0001047335
2025-11-07 2025-11-07
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2025 (November 7, 2025)
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
National HealthCare Corporation (“NHC”) issued a press release on November 7, 2025, announcing its September 30, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
(d) Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on November 7, 2025 by National HealthCare Corporation announcing September 30, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 7, 2025
By:
/s/
Brian F. Kidd
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
Aug 8, 2025
nhc20250806_8k.htm
false 0001047335
0001047335
2025-08-08 2025-08-08
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2025 (August 8, 2025)
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation)
001-13489
(Commission File Number)
52-2057472
(I.R.S. Employer Identification
No.)
100 E. Vine Street
Murfreesboro, Tennessee
(Address of Principal Executive
Offices)
37130
(Zip Code)
Registrant’s telephone number, including area code: (615) 890-2020
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
NHC
NYSE American
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
National HealthCare Corporation (“NHC”) issued a press release on August 8, 2025, announcing its June 30, 2025 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
(d) Exhibits.
Exhibit No.
Description of Exhibit
99.1
Copy of press release issued on August 8, 2025 by National HealthCare Corporation announcing June 30, 2025 earnings.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 8, 2025
By:
/s/ Brian F. Kidd
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
This page provides National HealthCare Corporation (NHC) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on NHC's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.